Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The future of drug development: the paradigm shift towards systems therapeutics
Meindert Danhof, Kevin Klein, Pieter Stolk, et al.
Drug Discovery Today (2018) Vol. 23, Iss. 12, pp. 1990-1995
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Satelliting traditional to smart healthcare advancement using artificial intelligence: A paradigm shift routing futuristic slant redefining
Bhupinder Singh, Anand Nayyar
Elsevier eBooks (2025), pp. 265-283
Closed Access | Times Cited: 1
An overview on transient receptor potential channels superfamily
Merab G. Tsagareli, Ivliane Nozadze
Behavioural Pharmacology (2019) Vol. 31, Iss. 5, pp. 413-434
Closed Access | Times Cited: 40
Assessment of Local Pharmaceutical Manufacturing Sector in a Low-income Country: A Descriptive Study
Tesfa Marew, Anteneh Belete, F.J.R. Richmond, et al.
Therapeutic Innovation & Regulatory Science (2025)
Open Access
Is 4D Printing at the Forefront of Transformations in Tissue Engineering and Beyond?
Sayan Basak
Deleted Journal (2024) Vol. 2, Iss. 2, pp. 587-600
Closed Access | Times Cited: 3
Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries
D. Coppens, Jarno Hoekman, Marie L. De Bruin, et al.
Cytotherapy (2020) Vol. 22, Iss. 10, pp. 592-600
Open Access | Times Cited: 22
Unraveling individual host–guest interactions in molecular recognition from first principles quantum mechanics: Insights into the nature of nicotinic acetylcholine receptor agonist binding
Michael E. Beck, Christoph Riplinger, Frank Neese, et al.
Journal of Computational Chemistry (2020) Vol. 42, Iss. 5, pp. 293-302
Open Access | Times Cited: 17
Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19
Rob C. van Wijk, Laurynas Mockeliūnas, Gerben van den Hoogen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Model-Informed Drug Discovery and Development Strategy for the Rapid Development of Anti-Tuberculosis Drug Combinations
Rob C. van Wijk, Rami Ayoun Alsoud, Hans Lennernäs, et al.
Applied Sciences (2020) Vol. 10, Iss. 7, pp. 2376-2376
Open Access | Times Cited: 13
Regulating Advanced Therapy Medicinal Products through the Hospital Exemption: An Analysis of Regulatory Approaches in Nine EU Countries
D. Coppens, Helga Gardarsdóttir, Marie L. De Bruin, et al.
Regenerative Medicine (2020) Vol. 15, Iss. 8, pp. 2015-2028
Open Access | Times Cited: 13
Four scenarios for the future of medicines and social policy in 2030
Hubert G. M. Leufkens, Zuzana Kusynová, Murray Aitken, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2252-2260
Open Access | Times Cited: 8
CNS Drug Discovery in Academia: Where Basic Research Meets Innovation
Jürg Gertsch, Andrea Chicca
ChemBioChem (2024)
Open Access | Times Cited: 1
Paving New Roads Towards Biodiversity-Based Drug Development in Brazil: Lessons from the Past and Future Perspectives
Fernão Castro Braga
Revista Brasileira de Farmacognosia (2021) Vol. 31, Iss. 5, pp. 505-518
Open Access | Times Cited: 10
Regulatory Toxicology
John W. Kille
Elsevier eBooks (2024), pp. 515-557
Closed Access | Times Cited: 1
Drug discovery and development: A historical overview, current challenges and perspectives
Chai Xin Yu, Chau Ling Tham
Life Sciences Medicine and Biomedicine (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Unmet Medical Need as a Driver for Pharmaceutical Sciences – A Survey Among Scientists
Zuzana Kusynová, Giovanni M. Pauletti, Hendrika A. van den Ham, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 111, Iss. 5, pp. 1318-1324
Open Access | Times Cited: 9
Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective
Bernhard Mörtl, Martin Dreyling, Christian Schmidt, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 22, Iss. 7, pp. 474-482
Closed Access | Times Cited: 8
A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs
G Kapitanov, J Chabot, Jatin Narula, et al.
Frontiers in Bioinformatics (2021) Vol. 1
Open Access | Times Cited: 4
NaClO‐Mediated Cross Installation of Indoles and Azoles Benefits Anticancer Hit Discovery
Changjun Yu, E Ruiyao, Xiaowei Zhang, et al.
ChemMedChem (2022) Vol. 18, Iss. 5
Closed Access | Times Cited: 3
Treatment patterns and factors associated with discontinuation of monoclonal antibodies
Muzoon Matar Saleh Alkaabi, Syed Arman Rabbani, Padma Gm Rao, et al.
SAGE Open Medicine (2024) Vol. 12
Open Access
Identification of Novel Candidate Targets for Fascaplysin through In Silico and In Vivo Analyses of Shared Targets among Structurally Similar Compounds
Ki-Hoon Park, Junyang Jung, Na Young Jeong
Pharmacognosy Magazine (2024)
Closed Access
Computational chemistry of natural product analogues
Sasadhar Majhi, Sivakumar Manickam
Elsevier eBooks (2024), pp. 395-437
Closed Access
Assessment of Local Pharmaceutical Manufacturing Sector in a Low-income Country: A Descriptive Study
Tesfa Marew, Anteneh Belete, F.J.R. Richmond, et al.
Research Square (Research Square) (2024)
Closed Access
Regulatory density as a means to refine current regulatory approaches for increasingly complex medicines
Kevin Klein, Pieter Stolk, Marie L. De Bruin, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 10, pp. 2221-2225
Open Access | Times Cited: 3
Personalized Data Analysis Approach for Assessing Necessary Hospital Bed-Days Built on Condition Space and Hierarchical Predictor
Nataliia Melnykova, Nataliya Shakhovska, Volodymyr Melnykov, et al.
Big Data and Cognitive Computing (2021) Vol. 5, Iss. 3, pp. 37-37
Open Access | Times Cited: 3
Industrialization of Quantitative Systems Pharmacology
Brian Topp, Maria E. Trujillo, Vikram Sinha
CPT Pharmacometrics & Systems Pharmacology (2019) Vol. 8, Iss. 6, pp. 356-358
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top